HeartWare releases clinical trial data

November 10, 2009 by MassDevice staff

A study of the Framingham, Mass.-based firm's miniature heart pump shows a 90 percent survival rate six months after implantation.

HeartWare releases clinical trial data

HeartWare International Inc. released data from a clinical trial of its miniature heart pump in patients with end-stage heart failure, showing survival rates of 90 percent and 84 percent after six months and two years, respectively.

The Framingham, Mass.-based firm's left ventricular assist device is designed to provide a bridge to heart transplant patients, improving their cardiac function while they await a donor organ.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.